Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at started coverage on shares of Arcadia Biosciences (NASDAQ:RKDAFree Report) in a research report report published on Thursday. The brokerage issued a sell rating on the basic materials company’s stock.

Several other analysts have also issued reports on the stock. Lake Street Capital upgraded shares of Arcadia Biosciences to a strong-buy rating in a research report on Tuesday, May 14th. HC Wainwright reissued a buy rating and set a $10.00 price objective on shares of Arcadia Biosciences in a research report on Friday, April 5th.

Get Our Latest Analysis on RKDA

Arcadia Biosciences Price Performance

NASDAQ RKDA opened at $2.93 on Thursday. The stock has a market capitalization of $3.98 million, a price-to-earnings ratio of -0.57 and a beta of 0.62. Arcadia Biosciences has a 1-year low of $1.85 and a 1-year high of $5.60. The business’s fifty day moving average price is $2.26 and its 200-day moving average price is $2.61.

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) last posted its earnings results on Thursday, May 9th. The basic materials company reported ($1.78) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.52) by $0.74. The company had revenue of $1.26 million for the quarter, compared to the consensus estimate of $1.20 million. Arcadia Biosciences had a negative return on equity of 84.27% and a negative net margin of 129.74%. During the same quarter in the prior year, the company earned ($3.83) earnings per share. Equities research analysts anticipate that Arcadia Biosciences will post -5.01 EPS for the current year.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Further Reading

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with's FREE daily email newsletter.